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Neurogenesis and synaptic plasticity can be stimulated in vivo in the brain. In this study, we hypothesized that in vivo expression
of reprogramming factors such as Klf4, Sox2, Oct4, and c-Myc would facilitate endogenous neurogenesis and functional recovery.
CD-1mice were induced at 1 week of age by unilaterally carotid artery ligation and exposure to hypoxia. At 6 weeks of age, mice
were injected GFP only or both four reprogramming factors and GFP into lateral ventricle. Passive avoidance task and open field
test were performed to evaluate neurobehavioral function. Neurogenesis and synaptic activity in the hippocampus were evaluated
using immunohistochemistry, qRT-PCR, and/or western blot analyses. Whereas BrdU+GFAP+ cells in the subgranular zone of
the hippocampus were not significantly different, the numbers of BrdU+𝛽III-tubulin+ and BrdU+NeuN+ cells were significantly
higher in treatment group than control group. Expressions of synaptophysin and PSD-95 were also higher in treatment group than
control group. Importantly, passive avoidance task and open field test showed improvement in long-term memory and decreased
anxiety in treatment group. In conclusion, in vivo expression of reprogramming factors improved behavioral functions in chronic
hypoxic-ischemic brain injury.Themechanisms underlying these repair processes included endogenous neurogenesis and synaptic
plasticity in the hippocampus.
1. Introduction
The strongly established idea that the adult brain has no
ability for generating new neurons is now controverted, and
recent studies have discovered that the adult mammalian
brain can generate new neurons [1, 2]. Even though many
studies had a doubt in this idea for a long time, it is now
established as the new idea that throughout adult life inmany
species, including humans, specific regions of the brain con-
tinuously generate new neurons [2, 3]. In two regions of the
adult brain, adult neurogenesis has been constantly observed.
Namely, in the subventricular zone (SVZ) of the lateral ven-
tricle and the subgranular zone of the hippocampus, the adult
neurogenesis is generated from neural stem cells (NSCs)
[4]. Previous researches in the past decade have clarified
procedures of adult neurogenesis, such as the proliferation
and the fate determination of NSCs, differentiation and mat-
uration of neurons, and the eventual integration of neurons
into the neural networks [2, 5].
The presence of NSCs and the existence of new neurons
at certain regions in the adult brain suggest that it may treat
incurable neurological diseases by inducing neurogenesis [6].
Previous studies with animal models have also shown that
new neural progenitor cells, which have possibility tomigrate
and effect on damaged regions, are produced at the SVZ [6–
8]. Other studies have confirmed that, even at the adult brain,
neurogenesis occurred in both the SVZ and subgranular zone
of the hippocampus following cerebral ischemia. When the
brain has ischemic damage, neuronal precursors of the SVZ
and subgranular zone move to the damaged sites [6, 9–11].
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Figure 1: Experimental design and intraventricular injection of reprogramming factors. (a) Schematic timeline of the experiment. (b) A brain
picture of chronic hypoxic-ischemic brain injury model. Scale bar = 0.5 cm. (c) At postnatal 6 weeks, mice were injected in the right side of
lateral ventricle with GFP and the four reprogramming factors, that is, Oct4, Sox2, c-Myc, and Klf4 (treatment group), or GFP only (control
group). (d) An image of GFP expression in the lateral ventricle. Scale bar = 200𝜇m. (e) Absence of dysplasia or tumor development in the
lateral ventricle. (f) Absence of dysplasia or tumor development in the hippocampus. Both samples of (e) and (f) were evaluated 8 weeks after
the treatment, and brain sections were stained with hematoxylin and eosin and observed using a microscope. Neither dysplasia nor tumors
were observed in any group. Scale bars = 200𝜇m. PAT, passive avoidance task; LV, lateral ventricle; DG, dentate gyrus.
Understanding the molecular control of endogenous NSC
activation and progenitor cell mobilization will likely give
various chances for the use of stimulated neuronal replace-
ment as a therapeutic approach [6, 12]. However, compen-
satory neurogenesis stimulated after brain injury is basically
limited, so it is now obvious that endogenous neurogenesis
should not be an individual concern for complete functional
recovery [6, 13].
Previous study has been reported that reprogramming
factors such as Oct4, Sox2, c-Myc, and Klf4 can convert
fibroblasts into pluripotent stem cells [14]. Enhanced cell pro-
liferation is the most noticeable and earliest response when
the reprograming factors are expressed [15]. This enhanced
proliferation is associated with the induction of proliferative
genes [16]. According to this observation, we suggested that
the in vivo expression of the four reprogramming factors
listed above would support in vivo cell proliferation in the
hippocampus and SVZ, a major process for recovery from
chronic hypoxic-ischemic brain injury.
2. Materials and Methods
2.1. Animals and Housing. All animals were housed in a stan-
dard cage (27 × 22.5 × 14 cm3) in a facility accredited by the
Association for Assessment and Accreditation of Laboratory
Animal Care (AAALAC) and provided food and water ad
libitum with alternating 12-hour light/dark cycles, according
to animal protection regulations. The experimental proce-
dures were approved by the Institutional Animal Care and
Use Committee (IACUC number 2016-0109 and number
2016-0070). A schematic timeline of this experiment from
birth to 14 weeks of age is provided in Figure 1(a).
2.2. Neonatal Hypoxic-Ischemic Brain Injury. Permanent
ischemic brain damage was induced in 7-day-old CD-1 (ICR)
mice (Orient, Seongnam, Korea), by unilateral right carotid
artery ligation. Hypoxic brain injury (8% O2 for 60 minutes)
was also induced as described previously [17–20]. Animals
with severe brain lesions covering more than 50% of the
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unilateral hemisphere were excluded from the criteria. Atmo-
sphere around mice was maintained at 37∘C within the
hypoxic chamber. Neonatal hypoxic-ischemic brain injury
model is shown in Figure 1(b).
2.3. Intraventricular Injection of Reprogramming Factors. At 6
weeks of age, a total of 32 mice were anesthetized with keta-
mine (100mg/kg; Huons, Gyeonggi-do, Korea) and xylazine
(10mg/kg; Bayer Korea, Seoul, Korea) by intraperitoneal (IP)
injection and were randomly assigned to either the control
group (green fluorescent protein (GFP) only, 𝑛 = 15) or the
treatment group (Oct4, Sox2, c-Myc, and Klf4, and GFP, 𝑛 =
15). Mice received intraventricular injection of GFP (1.5 ×
106 CIU/mL, 2 𝜇L volume, and 0.01 𝜇L/s infusion rate; Ther-
moFisher, Carlsbad, CA, USA) only or both GFP and four
reprogramming factors (1.5 × 106 CIU/mL, 2𝜇L volume, and
0.01 𝜇L/s infusion rate; CytoTune-iPS 2.0 Sendai Repro-
gramming Kit, ThermoFisher, Carlsbad, CA) using stereo-
taxic coordinates (AP +0.5mm from bregma; ML −0.7mm
from bregma; DV −2.0mm from dura) (Figure 1(c)). Mice
had recovered in a heating chamber at 37∘C after the surgical
treatment.
2.4. Passive Avoidance Task. To evaluate memory function
based on learning to avoid an aversive stimulus, a 2-compart-
ment step-through passive avoidance task (PAT) was con-
ducted [21–23]. The method was adapted from the previous
study for examination of the long-term memory [23].
2.5. Open Field Test. Openfield test is generally used to evalu-
ate locomotor activity and spontaneous exploration in a novel
environment [24, 25]. Activity monitoring was conducted in
a square area measuring 30 × 30.5 × 31 cm3. The area’s floor
was divided into 16 sectors. The 4 inner sectors marked out
the center, while the 12 outer sectors were defined as the
periphery. Total distance in the center was recorded as an
index of anxiety [26, 27]. Mice were placed individually into
the periphery of the area and were allowed to explore freely
for 15 minutes while being monitored with a video camera.
The resulting data were analyzed using the video tracking
system Smart Vision 2.5.21 (Panlab, Barcelona, Spain).
2.6. Immunohistochemistry. This method was adapted from
the previous study [17]. Immunohistochemistry was per-
formed as described previously [17]. Briefly, animals were
euthanized and perfused with 4% paraformaldehyde (PFA).
Harvested brain tissues were cryosectioned with a slice
thickness of 16 𝜇m and immunohistochemistry staining was
performed on 4 sections. All animals received an IP injection
of 5-bromo-2-deoxyuridine (BrdU) (50mg/kg) once a day
for 12 days, beginning 1 day after stereotaxic surgery, to
evaluate endogenous cell genesis and neurogenesis in the
subgranular zone of the hippocampus and SVZ. Eight weeks
after the treatment, the long-term survival of newly generated
neurons was evaluated in 3 mice from each of the control and
treatment groups (𝑛 = 3 per group). Sections were stained
with primary antibodies against BrdU (1 : 200, Abcam, Cam-
bridge, UK), 𝛽III-tubulin (1 : 400, Covance, Princeton, NJ,
USA), glial fibrillary acidic protein (GFAP) (1 : 400, Abcam),
Nestin (1 : 400, Abcam), synaptophysin (1 : 100, Abcam), and
postsynaptic density protein 95 (PSD-95) (1 : 100, Abcam)
and secondary antibodies such as Alexa Fluor 488 goat
anti-rat (1 : 400, Invitrogen, Carlsbad, CA, USA), Alexa Fluor
568 goat anti-rabbit (1 : 400, Invitrogen), and Alexa Fluor
594 goat anti-mouse (1 : 400, Invitrogen). Stained sections
were thenmounted on glass slides with fluorescent mounting
medium containing 4󸀠,6-diamidino-2-phenylindole (DAPI;
Vectashield, Vector, Burlingame, CA, USA). Stained sections
were analyzed using confocal microscopy (LSM700, Zeiss,
Gottingen,Germany). Images ofGFP expression in the lateral
ventricle were taken using a fluorescent microscope (Axio
Imager M2, Zeiss) and density was evaluated using ZEN
Imaging Software (blue edition, Zeiss).
2.7.Western Blot Analysis. Thismethodwas adapted from the
previous study [17]. To confirm the expression of synapto-
physin and PSD-95 in the hippocampus in the control and
treatment groups (𝑛 = 3 per group), 50𝜇g extracted proteins
were dissolved in sample buffer (60mM Tris–HCl, pH 6.8,
14.4mM b-mercaptoethanol, 25% glycerol, 2% SDS, and 0.1%
bromophenol blue; Invitrogen), incubated for 10 minutes at
70∘C, and separated on a 10% SDS reducing polyacrylamide
gel (Invitrogen). Separated proteins were then equally loaded
and transferred onto polyvinylidene difluoride membranes
(Invitrogen) using a Trans-Blot System (Novex Mini-Cell;
Invitrogen). Blots were blocked for 1 hour in Tris-buffered
saline (TBS) (10mM Tris-HCl, pH 7.5, and 150mM NaCl)
containing 5% nonfat dry milk (Bio-Rad) at room temper-
ature, washed three times with TBS, and incubated at 4∘C
overnight with a synaptophysin (1 : 1,000, Abcam) antibody
and a PSD-95 (1 : 1,000, Abcam) antibody in TBST (10mM
Tris, pH 7.5, 150mM NaCl, and 0.02% Tween 20) containing
3% nonfat dry milk. The next day, blots were washed three
times with TBST and incubated for 1 hour with horseradish
peroxidase-conjugated secondary antibodies (1 : 3,000, Santa
Cruz Biotechnology, Santa Cruz, CA,USA) at room tempera-
ture. A housekeeping gene was evaluated with actin-antibody
(1 : 1,000, Santa Cruz Biotechnology). After washing three
times with TBST, blots were visualized with an ECL detection
system (Amersham Pharmacia Biotech, Little Chalfont, UK).
Using ImageQuant LAS 4000 software (GE Healthcare Life
Science, Chicago, IL, USA), western blot results were saved
into TIFF image files, and then the images were analyzed
using Multi-Gauge (Fuji Photo Film, version 3.0, Tokyo,
Japan).
2.8. Quantitative Real-Time Reverse Transcription-Polymerase
Chain Reaction (qRT-PCR). cDNAs were synthesized from
sample RNAs with ReverTra Ace qPCR RTMaster Mix with
gDNA Remover (TOYOBO, Osaka, Japan). Then, 5 𝜇L of
cDNA in a total volume of 20𝜇L was used in the following
reaction. The following steps of qRT-PCR are the same
as the previous study [28]. The primers were as follows:
mouse PSD-95, 5󸀠-TCCCCATTTTCTCCCACACAC-3󸀠
and 5󸀠-ACGGCGTGGGGAGTTATGAT-3󸀠; mouse synap-
tophysin, 5󸀠-GTGCCAACAAGACGGAGAGT-3󸀠 and 5󸀠-
CACCCGAGGAGGAGTAGTCA-3󸀠; mouse glyceraldehyde
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Figure 2: Effects of reprogramming factor expression on neurobehavioral functions after chronic hypoxic-ischemic brain injury. Passive
avoidance task and open field test results showed that expression of the four reprogramming factors improved long-term memory and
decreased anxiety 8 weeks after the treatment. (a) Expression of the four reprogramming factors significantly improved retention test
performance 24 hours after an aversive stimulus 8 weeks after the treatment (140.9 ± 42.5 seconds) relative to that in the initial assessment
(57.9±15.3 seconds), whereas the performance was not statistically improved in the control group (𝑡 = 2.916, 𝑝 < 0.05; 𝑛 = 7 per group).The
result suggests that the expression of reprogramming factors improves long-term memory 8 weeks after the treatment. (b) The total distance
of movement was assessed for 15min.The percentage of the inner zone/outer zone increased in the treatment group (27.4 ± 1.3%) compared
to the control group (23.5 ± 1.1%) (𝑡 = 2.568, 𝑝 < 0.05; 𝑛 = 8 and 𝑛 = 9 per group, resp.). (c) Among the total of 16 zones, 4 central zones are
an inner zone, and 12 peripheral zones are an outer zone. ∗𝑝 < 0.05.
3-phosphate dehydrogenase (GAPDH), 5󸀠-CATCACTGC-
CACCCAGAAGACTG-3󸀠 and 5󸀠-ATGCCAGTGAGCTTC-
CCGTTCAG-3󸀠. GAPDH was used as the internal control.
2.9. Statistical Analyses. The numbers of BrdU+ cells,
BrdU+𝛽III tubulin+ cells, BrdU+NeuN+ cells, and
BrdU+GFAP+ cells in the hippocampus, the level of synaptic
proteins such as synaptophysin and PSD-95, and open field
test results were analyzed between the treatment and control
groups using independent 𝑡-test as implemented in SPSS
(version 18.0; Armonk, NY, USA). Neurobehavioral outcome
for passive avoidance task was compared between baseline
and 24 hours using paired 𝑡-test. Statistical significance was
accepted when 𝑝 < 0.05.
3. Results
3.1. In Vivo Reprogramming Factor Expression Improves Long-
Term Memory after Chronic Hypoxic-Ischemic Brain Injury.
To determine whether the in vivo expression of four repro-
gramming factors improved cognitive function, passive
avoidance task was performed before the surgical treatment
and 8 weeks after intervention in the control and treatment
groups (𝑛 = 7 per group). Expression of the reprogramming
factors significantly improved retention test performance 24
hours after an aversive stimulus at 8 weeks after the treatment
(140.9±42.5 seconds) relative to that in the initial assessment
(57.9 ± 15.3 seconds) (𝑡 = 2.916, 𝑝 < 0.05), whereas the
performance was not statistically improved in the control
group (Figure 2(a)).The result suggests that in vivo expression
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Table 1: Newly generated neurons in the hippocampus and subventricular zone after the in vivo expression of reprogramming factors. To
identify newly generated cells, mice were injected daily with BrdU up to 12 days. Eight weeks after the treatment, histological evaluations were
performed.
Group
Hippocampus Subventricular zone
BrdU+ BrdU+𝛽III-tubulin+ BrdU+NeuN+ BrdU+ BrdU+Nestin+ BrdU+GFAP+
(×103 cells/mm3) (×103 cells/mm3) (×103 cells/mm3) (×103 cells/mm3) (×103 cells/mm3) (×103 cells/mm3)
GFP 8.1 ± 2.0 3.0 ± 1.6 2.1 ± 1.6 29.6 ± 7.4 3.6 ± 1.5 5.7 ± 2.0
Rep + GFP 17.6 ± 1.9∗ 9.2 ± 2.3∗ 13.2 ± 5.1∗ 57.7 ± 4.1∗∗ 15.3 ± 2.6∗∗ 16.5 ± 4.8∗
Fold change 2.2 3.1 6.2 2.0 4.3 2.9
BrdU, 5-bromo-2-deoxyuridine; GFP, green fluorescent protein; Rep, reprogramming factors.
∗𝑝 < 0.05, ∗∗𝑝 < 0.01, and n = 3 per group.
of reprogramming factors improves long-term memory 8
weeks after the treatment. Additionally, when the step-
through latency was evaluated in the passive avoidance task,
there was no significant difference between sham-operated
control group (205.7 ± 55.7 seconds) and treatment group
(235.7±45.7 seconds) (𝑛 = 6 per group; Figure S2A in Supple-
mentaryMaterial available online at http://dx.doi.org/10.1155/
2016/2580837).
3.2. In Vivo Expression of Reprogramming Factors Decreases
Anxiety in Chronic Hypoxic-Ischemic Brain Injury. To evalu-
ate the effect of the four reprogramming factors on anxiety,
the results of open field test, 8 weeks after intervention, were
compared between the treatment and control groups (𝑛 = 8
and 9 per group, resp.). The total zone was divided into the
outer zone and inner zone (Figure 2(c)).Thepercentage of the
inner zone/outer zone increased after the in vivo expression
of the four reprogramming factors in the treatment group
(27.4 ± 1.3%) compared to the control group (23.5 ± 1.1%)
(𝑡 = 2.568, 𝑝 < 0.05; Figure 2(b)). When a ratio of distance
of inner zone over outer zone decreases, this ratio can be
the indication of the reduction of anxiety [27]. Therefore,
this result suggests that the in vivo expression of repro-
gramming factors decreased anxiety-related behavior. Addi-
tionally, when the percentage of the inner zone/outer zone
was evaluated in sham-operated control group (9.1 ± 2.0%)
and treatment group (10.3 ± 3.3%), there was no significant
difference between two groups (𝑛 = 6 per group; Figure S2B).
3.3. In Vivo Reprogramming Factor Expression Increases the
Number of New Neurons but Not Astrocytes in the Hippocam-
pus. Todetermine the density of proliferating cells in the sub-
granular zone of the hippocampus, BrdU+ cells were counted.
Thenumber of BrdU+ cells in the treatment group (17.6±1.9×
103 cells) was significantly 2.2 times higher than in the control
group (8.1 ± 2.0 × 103 cells) (𝑡 = 3.528, 𝑝 < 0.05; Figure 3(a)).
Meanwhile, to evaluate the cell fate of proliferating cells
in the hippocampus, double-staining of cells with BrdU
and cell type-specific markers such as 𝛽III-tubulin (Tuj1,
early neuronal marker), NeuN (mature neuronal maker), or
GFAP (astrocyte marker) was performed. The numbers of
BrdU+𝛽III-tubulin+ cells in the treatment group (9.2 ± 2.3 ×
103 cells) were significantly 3.1 times higher than in the con-
trol group (3.0 ± 1.6 × 103 cells) (𝑡 = 2.450, 𝑝 < 0.05; Figures
3(b), 3(d), and 3(e)), indicating that the in vivo expression of
reprogramming factors enhanced neurogenesis. The number
of BrdU+NeuN+ cells in the treatment group (13.2±5.0×103
cells) was also significantly 6.2 times higher than in the con-
trol group (2.1 ± 1.5 × 103 cells) (𝑡 = 2.297, 𝑝 < 0.05; Figures
3(c), 3(f), and 3(g)), suggesting that the newly generated neu-
rons differentiate into mature neurons. However, there were
no BrdU+GFAP+ cells in the hippocampus in either group
suggesting that neurogenesis in the hippocampus is towards
neurons, not astrocytes. The number of BrdU+ cells of two
weeks after the surgical treatment groups is shown in Figure
S1. The above values are described in Table 1.
3.4. In Vivo Expression of Reprogramming Factors Increases the
Number of Neural Precursor Cells in the Subventricular Zone.
To determine the density of proliferating cells in the SVZ of
the lateral ventricle, BrdU+ cells were counted. The number
of BrdU+ cells in the treatment group (57.7 ± 4.1 × 103 cells)
was 2.0 times higher than in the control group (29.6±7.4×103
cells) (𝑡 = 3.596, 𝑝 < 0.01; Figure 4(a)). Meanwhile, to
evaluate the proliferating cells in the SVZ, double-staining
of cells with BrdU and cell type-specific markers such as
Nestin (neural progenitor marker) and GFAP was used. The
numbers of BrdU+Nestin+ cells in the treatment group (15.3±
2.6×103 cells) were 4.3 times higher than in the control group
(3.6 ± 1.5 × 103 cells) (𝑡 = 3.868, 𝑝 < 0.01; Figures 4(b), 4(d),
and 4(e)), indicating that the in vivo expression of reprogram-
ming factors increased newly generated neural precursor
cells. The number of BrdU+GFAP+ cells in the treatment
group (16.5 ± 4.8 × 103 cells) was also 2.9 times higher than
in the control group (5.7 ± 2.0 × 103 cells) (𝑡 = 2.631,
𝑝 < 0.05; Figures 4(c), 4(f), and 4(g)), suggesting that the in
vivo expression of reprogramming factors increased neural
precursor cells and/or immature astrocytes in the SVZ. The
above results are described in Table 1.
3.5. In Vivo Expression of Reprogramming Factors Increases
Synapse Density in the Hippocampus. We evaluated expres-
sion levels of a presynaptic maker (synaptophysin) and
postsynaptic marker (PSD-95) to determine if reprogram-
ming factor expression increased density of synapse in the
hippocampus. Using qRT-PCR, we confirmed that the level
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Figure 3: The number of new neurons in the hippocampus increased by in vivo expression of reprogramming factors. At postnatal 6 weeks,
mice were injected with viral vector expressed GFP only (control group) or the four reprogramming factors and GFP (treatment group).
To identify newly generated cells, mice were injected daily with 5-bromo-2-deoxyuridine (BrdU) up to 12 days. Eight weeks after injection,
histological evaluations were performed. (a) The density of BrdU+ cells in the hippocampus was significantly higher in the treatment group
than in the control group (𝑡 = 3.528, 𝑝 < 0.05). (b-c) The density of newly generated neurons was determined through confocal microscopy
by calculating the density of cells triple positive for DAPI (blue, nuclei), BrdU (green), and cell type-specific markers such as 𝛽III-tubulin and
NeuN. The densities of BrdU+𝛽III-tubulin+ (b) and BrdU+NeuN+ (c) cells were significantly higher in the treatment group than the control
group (𝑡 = 2.450, 𝑝 < 0.05 and 𝑡 = 2.297, 𝑝 < 0.05, resp.). (d–g) Confocal microscope images are immunohistochemistry results. (e, g)
Cells with triple positive for DAPI, BrdU, and cell type-specific markers are indicated in the yellow box at the right panel. Scale bars = 50 𝜇m.
∗𝑝 < 0.05.
of PSD-95 was higher in the treatment group than the control
group (1.3 ± 0.1-fold, 𝑡 = 2.879, and 𝑝 < 0.01; Figure 5(a)).
We also confirmed that the level of synaptophysin was higher
in the treatment group than the control group (1.4 ± 0.1-fold,
𝑡 = 3.668, and 𝑝 < 0.01; Figure 5(a)). Using western blot
analysis, we confirmed that the level of PSD-95 was higher
in the treatment group than the control group (1.6 ± 0.1-fold,
𝑡 = 6.499, and𝑝 < 0.001; Figure 5(b)).We also confirmed that
the level of synaptophysin was higher in the treatment group
than the control group (1.3 ± 0.1-fold, 𝑡 = 3.136, and 𝑝 <
0.01; Figure 5(b)). Confocal images also showed that PSD-95
expression was higher in the treatment group (Figures 5(c)
and 5(d)). These results suggest that in vivo reprogramming
therapy increases hippocampal synaptic plasticity in chronic
hypoxic-ischemic brain injury.
4. Discussion
In our study, the reprogramming factors such as Oct4, Sox2,
c-Myc, and Klf4 were delivered by intraventricular injection
of viral vector, and expression of GFP was confirmed in the
lateral ventricle near the dentate gyrus. Nakatomi et al. [29]
reported that, following ischemic brain injury, adult neural
progenitors can be encouraged in situ by intraventricular
infusion of growth factors to substitute CA1 pyramidal neu-
rons in the hippocampus. Intraventricular infusion of growth
factors recruited the endogenous progenitor in situ, so mak-
ing huge regeneration of pyramidal neurons after ischemia
because hippocampal CA1 pyramidal neurons undertake
general degeneration following temporary ischemia [30–
32]. Using a similar appoach, activated neuronal progenitor
Neural Plasticity 7
GFP GFP+Rep
∗∗
0
20
40
60
80
Br
dU
+
ce
lls
 (×
10
3
/m
m
3
)
(a)
GFP
∗∗
0
5
10
15
20
25
Br
dU
+
N
es
tin
+
ce
lls
 (×
10
3
/m
m
3
)
GFP+Rep
(b)
GFP GFP+Rep
∗
Br
dU
+
𝛽
II
I-
G
FA
P+
0
5
10
15
20
25
ce
lls
 (×
10
3
/m
m
3
)
(c)
Nestin
BrdU
DAPI
GFP
(d)
Nestin
BrdU
DAPI
GFP+Rep
(e)
GFP
GFAP
BrdU
DAPI
(f)
GFAP
BrdU
DAPI
GFP+Rep
(g)
Figure 4: The number of neural progenitor cells in the subventricular zone increased by the in vivo expression of reprogramming factors.
(a) The density of BrdU+ cells in the subventricular zone was significantly higher in the treatment group than the control group (𝑡 = 3.596,
𝑝 < 0.01). (b-c) The density of neural progenitor cells was determined through confocal microscopy by calculating the density of cells triple
positive for DAPI (blue, nuclei), BrdU (green), and cell type-specific markers such as Nestin and GFAP. The densities of BrdU+Nestin+ cells
(b) and BrdU+GFAP+ cells (c) were significantly higher in the treatment group than the control group (𝑡 = 3.868, 𝑝 < 0.01 and 𝑡 = 2.631,
𝑝 < 0.05, resp.). (d–g) Confocal microscope images are immunohistochemistry results. (e, g) Cells with triple positive for DAPI, BrdU, and
cell type-specific markers are indicated in the yellow box at the right panel. Scale bars = 50𝜇m. ∗𝑝 < 0.05; ∗∗𝑝 < 0.01.
cells in the subgranular zone of the dentate gyrus migrate
and differentiate into new neurons [33], and subependymal
progenitors of the lateral ventricular wall might increase the
movement to the pools of neurogenic progenitors in the
hippocampus of the mammalian brain [12, 34, 35]. Taken
together, these results suggest that hippocampal neurogenesis
might be increased by delivering reprogramming factors into
the lateral ventricle.
Histological analysis in the hippocampus showed that
the in vivo expression of reprogramming factors enhanced
the proliferative generation of neurons, but not astrocytes.
In a previous study, when double-labeling was performed,
approximately 60% of BrdU+ cells in the granule cell layer
were also NeuN double-stained, indicating differentiation
into neurons. None of the BrdU+ cells in the granule cell
layer appeared to differentiate into GFAP+ astrocytes [36].
However, it cannot be ruled out that these cells could be also
derived from other cell types because in vivo overexpression
of reprogramming factors can epigenetically activate cells
so that they are in an intermediate plastic state that allows
them to have an alternative fate [37–41]. Tentatively, our study
demonstrated that four reprogramming factors may influ-
ence endogenous progenitors in the hippocampus to differen-
tiate into mature neurons.
In addition, histological analysis in the SVZ showed that
the in vivo expression of reprogramming factors increased
the neural precursor cells. In the SVZ, stem cell astrocyte
marker (type B cells, glial fibrillary acidic protein expressing
(GFAP)) also shared neural stem cell marker (Nestin) [42,
43]. Thus, the GFAP+ cells generated by reprogramming
factor expression might be a novel cell source with stem cell
potential in the SVZ of the injured brain [28, 43].
For the learning of new memories, hippocampal neuro-
genesis may be essential [44]. Both learning and the affective
state are related to the alteration of adult hippocampal neu-
rogenesis [45]. In previous studies, genetic ablation of new
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Figure 5: Synaptic density in the hippocampus increased by in vivo expression of reprogramming factors.The expression levels of the synaptic
markers of PSD-95 and synaptophysin in the hippocampus were determined by quantitative real-time reverse transcription-polymerase
chain reaction (qRT-PCR) and western blot (𝑛 = 3 per group). (a) qRT-PCR analysis confirmed that PSD-95 and synaptophysin levels were
significantly higher in the treatment group than the control group (𝑡 = 2.879, 𝑝 < 0.01; 𝑡 = 3.668, 𝑝 < 0.01, resp.). (b) Western blot analysis
also confirmed that PSD-95 and synaptophysin levels were significantly higher in the treatment group than the control group (𝑡 = 6.499,
𝑝 < 0.001; 𝑡 = 3.136, 𝑝 < 0.01, resp.). (c, d) Confocal microscope images are immunohistochemistry results that showed the area of the
dentate gyrus in the hippocampus. The expression of PSD-95 in the yellow box represented the difference of synaptic density in the control
(c) and treatment (d) group. Scale bars = 50𝜇m. ∗∗𝑝 < 0.01; ∗∗∗𝑝 < 0.001.
neurons in the hippocampus was associated with learning
and memory impairment, while induction of hippocam-
pal neurogenesis alleviated such lesion-induced impairment
[46, 47]. Therefore, new neurons in hippocampus play an
important role in the hippocampus-related behaviors such
as learning and memory [48]. In particular, an increase in
neurogenesis, and thus an increase in neural plasticity, may
improve performance in learning and memory tasks [44].
Conversely, blocking neurogenesis may be the cause of the
observable decline in performance in various learning- and
memory-related tasks [44].
In our study, a ratio of distance in the center and
periphery was recorded as an index of anxiety.When amouse
is placed in a foreign environment, it intends to stay in the
outer zone. After it adapts in the environment and its anxiety
decreases, the spending time and distance increase in the
inner zone. Therefore, increase of spending time or distance
in the central part and of the ratio central over total loco-
motion indicates decrease of anxiety [27]. Several researchers
have suggested a link between hippocampal neurogenesis
and anxiety-related behaviors. Revest et al. convincingly
explained the connection between neurogenesis and anxiety-
related behavior [49]. In that study, the authors demonstrated
that deficits in hippocampal neurogenesis via specific abla-
tion of newborn neurons in the adult dentate gyrus resulted
in anxious behavior [50]. Furthermore, Dias and colleagues
also found a decreased number of immature neurons in the
dentate gyrus of a rodentmodel with generalized anxiety [51].
Consistent with the previous studies [44–51], we confirmed
that the in vivo expression of reprogramming factors facil-
itated hippocampal neurogenesis and hippocampus-related
behavioral outcomes such as increased long-term memory
and decreased anxiety-related behavior. Additionally, when
neurobehavioral tests were performed in sham-operated
control group and treatment group, there was no significant
difference between two groups. Therefore, it showed that
the in vivo expression of reprogramming factors might be
effective in the microenvironment of the injured brain.
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Our qRT-PCR, western blotting, and immunohistochem-
istry results showed that in vivo reprogramming therapy
increased expression of synaptic proteins such as the presy-
naptic marker, synaptophysin, and postsynaptic marker,
PSD-95, relative to the control group. PSD-95 is a core
component of the PSD and a keymolecule inmature synapses
[52].Moreover, maturation of synapse—presynaptic terminal
and postsynaptic component—can be labeled by PSD-95
[53]. In previous studies, targeted disruption of PSD-95
alters activity-dependent synaptic plasticity and learning.The
reason of why PSD-95 mutant mice are impaired in spatial
learning can be explained by these abnormalities in synaptic
plasticity [54, 55]. In addition, PSD-95 mutant mice exhibit
severe deficits in spatial, working, and distress memory and
abnormal anxiety, and behaviors are likely to be related
to abnormal synaptic transmission in the hippocampus,
especially dentate gyrus synapses [52]. Here we confirmed
that increased expression of PSD-95 and synaptophysin
was related to improved long-term memory and decreased
anxiety due to enhanced synaptic plasticity.
5. Conclusions
Taken together, the in vivo expression of four reprogram-
ming factors improved long-term memory and decreased
anxiety in the animal model of chronic hypoxic-ischemic
brain injury. Recovery of hippocampus-related behavior was
associated with enhanced hippocampal neurogenesis and
synaptic plasticity.
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